Robert Lechleider sold $1.1M of Immunome (IMNM)

Executed Jun 25, disclosed Jun 29, 4 days later.

Value, as filed

$1.1M

55,000 sh across 2 lots

Executed

Jun 25

the trade date, as filed

Disclosed

Jun 29

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Robert Lechleider Chief Medical Officer profile →

Robert Lechleider (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Immunome, Inc. (IMNM). The largest single filing was $1.2M of IMNM (55,000 sh across 3 lots, as filed), executed Jul 2.

The name

IMNM

Immunome, Inc. IMNM · Healthcare · 26 filings in 24 months ticker →

Healthcare · Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-dr…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Robert Lechleider in IMNM

IMNMSALE Immunome, Inc. $1.2M
55,000 sh across 3 lots
Exec Jul 2
Filed Jul 7 · 5:42 PM ET IMNMPURCHASE Immunome, Inc. $150K
15,805 sh × $9.48
Exec Nov 21 2024
Filed Nov 25 2024 · 5:30 PM ET